Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Supernus Pharmaceuticals Inc shares valued at $36,292 were sold by Rubin Jonathan on Feb 21 ’25. At $39.15 per share, Rubin Jonathan sold 927 shares. The insider’s holdings dropped to 7,853 shares worth approximately $0.25 million following the completion of this transaction.
Also, Bhatt Padmanabh P. sold 9,477 shares, netting a total of over 376,237 in proceeds. Following the sale of shares at $39.70 each, the insider now holds 10,149 shares.
Before that, Bhatt Padmanabh P. had sold 2,573 shares from its account. In a trade valued at $101,942, the Sr. VP of IP, CSO traded Supernus Pharmaceuticals Inc shares for $39.62 each. Upon closing the transaction, the insider’s holdings decreased to 2,573 shares, worth approximately $0.32 million.
As published in a research note from Cantor Fitzgerald on February 19, 2025, Supernus Pharmaceuticals Inc [SUPN] has been rated down from an Overweight to a Neutral and the price target has been revised to $36 from $57. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early January. As of September 11, 2024, Piper Sandler has decreased its “an Overweight” rating to a “Neutral” for SUPN.
Analyzing SUPN Stock Performance
During the last five days, there has been a drop of approximately -1.91%. Over the course of the year, Supernus Pharmaceuticals Inc shares have dropped approximately -13.22%. Shares of the company reached a 52-week high of $40.28 on 02/05/25 and a 52-week low of $30.37 on 02/26/25. A 50-day SMA is recorded $36.35, while a 200-day SMA reached $33.15.
Support And Resistance Levels for Supernus Pharmaceuticals Inc (SUPN)
According to the 24-hour chart, there is a support level at 30.79, which, if violated, would cause prices to drop to 30.20. In the upper region, resistance lies at 31.97. The next price resistance is at 32.57. RSI (Relative Strength Index) is 33.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.05, which suggests the price will decrease in the coming days. Percent R is at 77.56%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
